COGT Annual Working Capital
$232.60 M
-$5.51 M-2.32%
31 December 2023
Summary:
As of January 23, 2025, COGT annual working capital is $232.60 million, with the most recent change of -$5.51 million (-2.32%) on December 31, 2023. During the last 3 years, it has risen by +$785.00 thousand (+0.34%). COGT annual working capital is now -2.32% below its all-time high of $238.12 million, reached on December 31, 2022.COGT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COGT Quarterly Working Capital
$288.48 M
-$41.49 M-12.57%
30 September 2024
Summary:
As of January 23, 2025, COGT quarterly working capital is $288.48 million, with the most recent change of -$41.49 million (-12.57%) on September 30, 2024. Over the past year, it has dropped by -$41.49 million (-12.57%). COGT quarterly working capital is now -28.81% below its all-time high of $405.22 million, reached on March 31, 2024.COGT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COGT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.3% | -12.6% |
| 3 y3 years | +0.3% | +51.2% |
| 5 y5 years | +314.9% | +1739.8% |
COGT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.3% | +13.2% | -28.8% | +63.1% |
| 5 y | 5-year | -2.3% | +750.7% | -28.8% | +1739.8% |
| alltime | all time | -2.3% | +750.7% | -28.8% | +2251.7% |
Cogent Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $288.48 M(-12.6%) |
| June 2024 | - | $329.97 M(-18.6%) |
| Mar 2024 | - | $405.22 M(+74.2%) |
| Dec 2023 | $232.60 M(-2.3%) | $232.60 M(-7.4%) |
| Sept 2023 | - | $251.23 M(-18.6%) |
| June 2023 | - | $308.76 M(+50.5%) |
| Mar 2023 | - | $205.15 M(-13.8%) |
| Dec 2022 | $238.12 M(+15.8%) | $238.12 M(-12.7%) |
| Sept 2022 | - | $272.87 M(-10.0%) |
| June 2022 | - | $303.02 M(+71.3%) |
| Mar 2022 | - | $176.85 M(-14.0%) |
| Dec 2021 | $205.56 M | $205.56 M(+7.7%) |
| Sept 2021 | - | $190.79 M(-8.1%) |
| June 2021 | - | $207.67 M(-7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $223.83 M(-3.4%) |
| Dec 2020 | $231.82 M(+747.8%) | $231.82 M(+104.6%) |
| Sept 2020 | - | $113.30 M(+622.5%) |
| June 2020 | - | $15.68 M(-28.5%) |
| Mar 2020 | - | $21.93 M(-19.8%) |
| Dec 2019 | $27.34 M(-51.2%) | $27.34 M(+16.1%) |
| Sept 2019 | - | $23.55 M(-31.3%) |
| June 2019 | - | $34.29 M(-38.8%) |
| Dec 2018 | $56.06 M(+79.7%) | $56.06 M(-11.2%) |
| Sept 2018 | - | $63.12 M(-12.7%) |
| June 2018 | - | $72.30 M(+489.4%) |
| Mar 2018 | - | $12.27 M(-60.7%) |
| Dec 2017 | $31.19 M(-48.9%) | $31.19 M |
| Dec 2016 | $60.99 M | - |
FAQ
- What is Cogent Biosciences annual working capital?
- What is the all time high annual working capital for Cogent Biosciences?
- What is Cogent Biosciences annual working capital year-on-year change?
- What is Cogent Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Cogent Biosciences?
- What is Cogent Biosciences quarterly working capital year-on-year change?
What is Cogent Biosciences annual working capital?
The current annual working capital of COGT is $232.60 M
What is the all time high annual working capital for Cogent Biosciences?
Cogent Biosciences all-time high annual working capital is $238.12 M
What is Cogent Biosciences annual working capital year-on-year change?
Over the past year, COGT annual working capital has changed by -$5.51 M (-2.32%)
What is Cogent Biosciences quarterly working capital?
The current quarterly working capital of COGT is $288.48 M
What is the all time high quarterly working capital for Cogent Biosciences?
Cogent Biosciences all-time high quarterly working capital is $405.22 M
What is Cogent Biosciences quarterly working capital year-on-year change?
Over the past year, COGT quarterly working capital has changed by -$41.49 M (-12.57%)